Skip to main content
. 2022 Apr 21;27(5):338–e368. doi: 10.1093/oncolo/oyab065
Name *NC/NA 1 2 3 4 5 All Grades
Neutrophil count decreased 17% 13% 13% 46% 13% 0% 83%
White blood cell decreased 67% 4% 13% 17% 0% 0% 33%
Lymphocyte count decreased 92% 0% 4% 4% 0% 0% 8%
Fatigue 13% 54% 17% 17% 0% 0% 88%
Anemia 25% 54% 17% 4% 0% 0% 75%
Left ventricular systolic dysfunction 83% 0% 13% 4% 0% 0% 17%
Pneumonitis 100% 0% 0% 0% 0% 0% 0%
Pleural effusion 100% 0% 0% 0% 0% 0% 0%
Dyspnea 92% 0% 8% 0% 0% 0% 8%
ALT, SGPT (serum glutamic pyruvic transaminase) 83% 8% 0% 4% 4% 0% 17%
AST, SGOT(serum glutamic oxaloacetic transaminase) 79% 13% 0% 4% 4% 0% 21%
Blood bilirubin increased 92% 4% 0% 4% 0% 0% 8%
Hyponatremia 88% 4% 0% 8% 0% 0% 13%
Potassium, serum-low (hypokalemia) 100% 0% 0% 0% 0% 0% 0%
Hypercalcemia 100% 0% 0% 0% 0% 0% 0%
Hypoalbuminemia 100% 0% 0% 0% 0% 0% 0%
Hepatobiliary disorders - Other, specify 96% 0% 0% 4% 0% 0% 4%
Hypertension 96% 0% 0% 4% 0% 0% 4%
Blood and lymphatic system 
disorders - Other, specify 100% 0% 0% 0% 0% 0% 0%
Nausea 33% 38% 25% 4% 0% 0% 67%
Vomiting 63% 29% 4% 4% 0% 0% 38%
Peripheral sensory neuropathy 100% 0% 0% 0% 0% 0% 0%
Alopecia 25% 42% 33% 0% 0% 0% 75%
Skin and subcutaneous tissue 
disorders - Other, specify 50% 50% 0% 0% 0% 0% 50%
Diarrhea 58% 42% 0% 0% 0% 0% 42%
Platelet count decreased 79% 17% 4% 0% 0% 0% 21%
Mucositis oral 67% 21% 13% 0% 0% 0% 33%
Activated partial thromboplastin time prolonged 96% 0% 0% 4% 0% 0% 4%
Lung infection 96% 0% 0% 4% 0% 0% 4%
Syncope 96% 0% 0% 4% 0% 0% 4%
Pain in extremity 100% 0% 0% 0% 0% 0% 0%
Chest wall pain 96% 0% 4% 0% 0% 0% 4%
Back pain 96% 0% 4% 0% 0% 0% 4%
Buttock pain 100% 0% 0% 0% 0% 0% 0%
Neck pain 100% 0% 0% 0% 0% 0% 0%
Voice changes/dysarthria (e.g., hoarseness, loss or alteration invoice,laryngitis) 100% 0% 0% 0% 0% 0% 0%